Literature DB >> 1877229

Is deleting the digital rectal examination a good idea?

M A Sutton1, R P Gibbons, R J Correa.   

Abstract

Many groups have taken the position that the digital rectal examination should be discontinued as part of the annual screening physical examination. We examined the effects of not doing a digital rectal examination on the early diagnosis of prostate cancer. The average time since a previous rectal examination increased as the stage of cancer increased. The digital rectal examination proved to be a relatively insensitive test, with 40% of stage D cancers being detected initially within 12 months of the most recent examination. Nevertheless, an annual digital rectal examination did detect a greater percentage of lower stage (and thus more localized and potentially curable) cancers when repeated within 12 months. When the last rectal examination was more than 24 months previous, cancers detected were more likely to be advanced. Without a digital rectal examination, patients would have their disease detected only by the presence of symptoms. When it was done because of symptoms, 81% of our patients had stage D cancers compared with 32% of stage B and 38% of stage C patients. Without the routine use of this examination, patients with prostate cancer would be more likely to have higher stage and less potentially curable lesions at the time of diagnosis. We conclude that the digital rectal examination remains an important part of routine annual physical examinations.

Entities:  

Mesh:

Year:  1991        PMID: 1877229      PMCID: PMC1002909     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  21 in total

1.  Latent carcinoma of the prostate.

Authors:  L M FRANKS
Journal:  J Pathol Bacteriol       Date:  1954-10

2.  Carcinoma of the prostate: five-year followup of patients treated by radical surgery.

Authors:  J C KIMBROUGH
Journal:  J Urol       Date:  1956-09       Impact factor: 7.450

3.  Total prostatectomy for clinically localized prostatic cancer: long-term results.

Authors:  R P Gibbons; R J Correa; G E Brannen; R M Weissman
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

4.  Prostate specific antigen. Experimental and clinical observations.

Authors:  P R Huber; Y Schnell; F Hering; G Rutishauser
Journal:  Scand J Urol Nephrol Suppl       Date:  1987

5.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

6.  Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.

Authors:  J E McNeal; H M Price; E A Redwine; F S Freiha; T A Stamey
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

7.  An evaluation of five tests to diagnose prostate cancer.

Authors:  P Guinan; P Ray; R Bhatti; M Rubenstein
Journal:  Prog Clin Biol Res       Date:  1987

8.  Routine screening for prostate cancer using the digital rectal examination.

Authors:  G W Chodak; P Keller; H Schoenberg
Journal:  Prog Clin Biol Res       Date:  1988

9.  Background for screening--epidemiology and cost effectiveness.

Authors:  M I Resnick
Journal:  Prog Clin Biol Res       Date:  1988

10.  Prostate cancer: comparison of transrectal US and digital rectal examination for screening.

Authors:  F Lee; P J Littrup; S T Torp-Pedersen; C Mettlin; T A McHugh; J M Gray; G H Kumasaka; R D McLeary
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

View more
  2 in total

1.  The digital rectal examination of women.

Authors:  P Tompkins
Journal:  West J Med       Date:  1991-11

2.  A clinical study on surgical causes of Hematuria.

Authors:  Kewithinwangbo Newme; Ranendra Hajong; Ratna Kanta Bhuyan
Journal:  J Family Med Prim Care       Date:  2021-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.